INS and Stroke: In the subgroup analyses, subjects in GGT ASV quartile 4 consistently had an increased risk for all-cause mortality and stroke during follow up, with the exception of those with a history of insulin treatment or 4–6 classes of oral antidiabetic drugs in the stroke analysis (Fig. 4 and Supplementary Figure S2).